BioTech Medicare Advantage is bad for patients and bad for investors In 2023, enrollment in Medicare Advantage, the version of Medicare run by private insurers, surpassed 50% of eligible beneficiaries for the very first time. Going Read More ยป Wendell Potter and Philip Verhoef February 28, 2024